The androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors that plays a critical role in regulating expression of genes involved in prostate development and transformation. Upon hormone binding, the AR associates with numerous co-regulator proteins that regulate the activation status of target genes via flux to the post-translational modification status of histones and the receptor. Here we show that the AR interacts with and is directly methylated by the histone methyltransferase enzyme SET9. Methylation of the AR on lysine 632 is necessary for enhancing transcriptional activity of the receptor by facilitating both inter-domain communication between the N- and C-termini and recruitment to androge...
Prostate cancer progression to castration refractory disease is associated with anomalous transcript...
The classical action of androgen receptor (AR) is to regulate gene transcriptional processes via AR ...
Antiandrogen strategies remain the prostate cancer treatment backbone, but drug resistance develops....
PhD ThesisProstate cancer is the leading cause of cancer-related death in western men and results i...
none28siThe evolution of prostate cancer from an androgen-dependent state to one that is androgen-in...
SummaryThe evolution of prostate cancer from an androgen-dependent state to one that is androgen-ind...
We demonstrate that the androgen receptor (AR) regulates a transcriptional program of DNA repair gen...
INSTRUCTIONS: Please enter one of the following Topic Classifications in the section below: Bioinfo...
Prostate cancer is the most common cancer in men in the United States, and it is the second leading ...
Prostate cancer is the most commonly diagnosed cancer in men all over the world. Localized cancers i...
The androgen receptor (AR) is a ligand-dependent transcription factor. Binding of androgens induces...
Androgens regulate the physiological development of the prostate and the pathology of prostate cance...
ABSTRACT We demonstrate that the androgen receptor (AR) regulates a transcriptional pro-gram of DNA ...
The androgen receptor (AR) is the critical driver in prostate cancer and exerts its function mainly ...
Prostate cancer is the most common cancer in men in the United States, and it is the second leading ...
Prostate cancer progression to castration refractory disease is associated with anomalous transcript...
The classical action of androgen receptor (AR) is to regulate gene transcriptional processes via AR ...
Antiandrogen strategies remain the prostate cancer treatment backbone, but drug resistance develops....
PhD ThesisProstate cancer is the leading cause of cancer-related death in western men and results i...
none28siThe evolution of prostate cancer from an androgen-dependent state to one that is androgen-in...
SummaryThe evolution of prostate cancer from an androgen-dependent state to one that is androgen-ind...
We demonstrate that the androgen receptor (AR) regulates a transcriptional program of DNA repair gen...
INSTRUCTIONS: Please enter one of the following Topic Classifications in the section below: Bioinfo...
Prostate cancer is the most common cancer in men in the United States, and it is the second leading ...
Prostate cancer is the most commonly diagnosed cancer in men all over the world. Localized cancers i...
The androgen receptor (AR) is a ligand-dependent transcription factor. Binding of androgens induces...
Androgens regulate the physiological development of the prostate and the pathology of prostate cance...
ABSTRACT We demonstrate that the androgen receptor (AR) regulates a transcriptional pro-gram of DNA ...
The androgen receptor (AR) is the critical driver in prostate cancer and exerts its function mainly ...
Prostate cancer is the most common cancer in men in the United States, and it is the second leading ...
Prostate cancer progression to castration refractory disease is associated with anomalous transcript...
The classical action of androgen receptor (AR) is to regulate gene transcriptional processes via AR ...
Antiandrogen strategies remain the prostate cancer treatment backbone, but drug resistance develops....